Prognostic Significance of Time Between Balloon and Peak CK-MB in AMI Patients Undergoing Primary PCI
- PMID: 40340090
- PMCID: PMC12081220
- DOI: 10.1016/j.jacasi.2024.12.013
Prognostic Significance of Time Between Balloon and Peak CK-MB in AMI Patients Undergoing Primary PCI
Abstract
Background: Peak creatine kinase-MB (CK-MB) level is an established predictor of clinical outcomes following acute myocardial infarction (AMI). However, the significance of the duration between balloon inflation and peak CK-MB level (BP time) after primary percutaneous coronary intervention (PCI) remains underexplored in terms of prognostic impact.
Objectives: This study aimed to elucidate the relationship between BP time and prognostic outcomes in patients with AMI.
Methods: In this multicenter observational study, 935 AMI patients who underwent primary PCI and achieved TIMI flow grade 3 on final angiography were included. CK-MB levels were measured systematically at admission and at 3-hour intervals post-PCI. Based on a BP time threshold of 553 minutes, patients were categorized into 2 groups: the long BP-time group (n = 183) and the short BP-time group (n = 752).
Results: The mean age of the patients was 67 years, with a median BP time of 334 minutes (Q1-Q3: 248-491 minutes). The long BP-time group exhibited a higher prevalence of male patients and a history of prior PCI. Cardiovascular mortality was significantly greater in the long BP-time group (log-rank test: P = 0.002). Multivariable Cox regression analysis indicated that a prolonged BP time was independently associated with increased cardiovascular mortality (HR: 2.63; 95% CI: 1.19-5.78).
Conclusions: Our findings reveal a significant association between BP time and 1-year cardiovascular mortality in patients with AMI. As a readily assessable parameter, BP time can be a valuable tool for early mortality risk stratification in patients post-primary PCI. (Prognostic Implications of Time between Balloon to Peak Creatinine Kinase-MB in patients with Acute Myocardial Infarction Undergoing Primary PCI: Multicenter Cohort Study; UMIN000049942).
Keywords: acute myocardial infarction; creatine kinase-MB; percutaneous coronary intervention; prognosis.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures This study was not financially supported by any company, grant, or fund. The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures




Similar articles
-
Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.Am Heart J. 2008 Apr;155(4):673-9. doi: 10.1016/j.ahj.2007.11.004. Epub 2008 Feb 21. Am Heart J. 2008. PMID: 18371475
-
Implications of Periprocedural Myocardial Biomarker Elevations and Commonly Used MI Definitions After Left Main PCI.JACC Cardiovasc Interv. 2021 Aug 9;14(15):1623-1634. doi: 10.1016/j.jcin.2021.05.006. JACC Cardiovasc Interv. 2021. PMID: 34353593
-
Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction.J Am Coll Cardiol. 2006 Mar 7;47(5):951-61. doi: 10.1016/j.jacc.2005.12.003. Epub 2006 Feb 10. J Am Coll Cardiol. 2006. PMID: 16516077
-
Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.Ther Adv Cardiovasc Dis. 2012 Jun;6(3):101-14. doi: 10.1177/1753944712446670. Epub 2012 May 4. Ther Adv Cardiovasc Dis. 2012. PMID: 22562999 Review.
-
Prognostic value of creatine kinase-myocardial band isoenzyme elevation following percutaneous coronary intervention: a meta-analysis.Catheter Cardiovasc Interv. 2013 May;81(6):959-67. doi: 10.1002/ccd.24542. Epub 2012 Nov 14. Catheter Cardiovasc Interv. 2013. PMID: 22744792 Review.
Cited by
-
CK-MB Kinetics as a Superior Prognostic Indicator in Primary PCI: Moving Beyond TIMI Flow Grade 3.JACC Asia. 2025 May;5(5):660-662. doi: 10.1016/j.jacasi.2025.02.004. Epub 2025 Apr 15. JACC Asia. 2025. PMID: 40237689 Free PMC article.
References
-
- Collet J.P., Thiele H., Barbato E., et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42:1289–1367. - PubMed
-
- Halkin A., Stone G.W., Grines C.L., et al. Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol. 2006;47:951–961. - PubMed
-
- Dohi T., Maehara A., Brener S.J., et al. Utility of peak creatine kinase-MB measurements in predicting myocardial infarct size, left ventricular dysfunction, and outcome after first anterior wall acute myocardial infarction (from the INFUSE-AMI trial) Am J Cardiol. 2015;115:563–570. - PubMed
-
- Chia S., Senatore F., Raffel O.C., Lee H., Wackers F.J., Jang I.K. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2008;1:415–423. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous